Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|Fluoxymesterone||Halotestin||Androfluorene||Hormone - Anti-estrogens 17||Halotestin (fluoxymesterone) is a synthetic derivative of testosterone that suppresses estrogen and can potentially result in anti-tumor activity (NCI Drug Dictionary).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Unknown unknown||breast cancer||not applicable||Fluoxymesterone||Phase I||Actionable||In a Phase I study, rates of overall survival and relapse-free survival did not differ between early stage breast cancer patients treated with Halotestin (fluoxymesterone) and Nolvadex (tamoxifen) combined versus those treated with Nolvadex (Tamoxifen) alone (PMID: 16538529).||16538529|
|Unknown unknown||breast cancer||not applicable||Fluoxymesterone||Case Reports/Case Series||Actionable||In a Phase II trial, a patient with advanced breast cancer that developed resistance to long term hormonal therapy demonstrated sensitivity to Halotestin (fluoxymesterone) (PMID: 1590276).||1590276|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status|